【结 构 式】 |
【分子编号】56012 【品名】1H-pyrazol-5-amine; 1H-pyrazol-5-ylamine 【CA登记号】916420-28-5 |
【 分 子 式 】C3H5N3 【 分 子 量 】83.09292 【元素组成】C 43.36% H 6.07% N 50.57% |
合成路线1
该中间体在本合成路线中的序号:(I)5-Butyl-7-hydroxypyrazolo[1,5-a]pyrimidine (III) was prepared by condensation of 3-aminopyrazole (I) with methyl 3-oxoheptanoate (II) in refluxing toluene. Treatment of (III) with POCl3 in the presence of Et3N furnished the 7-chloro derivative (IV), which was then heated with aqueous ammonia in a sealed tube to afford the amino pyrazolopyrimidine (V). Finally, acylation of amine (V) with 3,4,5-trimethoxybenzoyl chloride (VI) led to the title amide.
【1】 Shoji, Y.; Yasuda, T.; Inoue, M.; Okamura, T.; Hashimoto, K.; Ohara, M. (Otsuka Pharmaceutical Co., Ltd.); Pyrazolo[1,5-a]pyrimidine deriv.. EP 0714898; JP 1996310951; JP 1996311068; US 5707997; WO 9535298 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 56012 | 1H-pyrazol-5-amine; 1H-pyrazol-5-ylamine | 916420-28-5 | C3H5N3 | 详情 | 详情 |
(II) | 56013 | 3-Ketoheptanoic acid methyl ester; 3-Oxokenanthic acid mehyl ester; Methyl 3-oxoheptanoate | 39815-78-6 | C8H14O3 | 详情 | 详情 |
(III) | 56014 | 5-butylpyrazolo[1,5-a]pyrimidin-7-ol | C10H13N3O | 详情 | 详情 | |
(IV) | 56015 | 5-butyl-7-chloropyrazolo[1,5-a]pyrimidine | C10H12ClN3 | 详情 | 详情 | |
(V) | 56016 | 5-butylpyrazolo[1,5-a]pyrimidin-7-amine; 5-butylpyrazolo[1,5-a]pyrimidin-7-ylamine | C10H14N4 | 详情 | 详情 | |
(VI) | 13571 | 3,4,5Ttrimethoxybenzoyl chloride | 4521-61-3 | C10H11ClO4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(XI)Bromination of 5-aminopyrazole (XI) with Br2 in AcOH gives 4-bromo-5-aminopyrazole (XII), which is cyclized with N-[3-[3-(dimethylamino)-2-propenoyl]phen-yl]-N-methylacetamide (X) in AcOH to yield the 3-bromo-pyrazolo[1,5-a]pyrimidine derivative (XIII). Finally, this compound can be condensed with either 2-thienylcarbonyl chloride (XIV) by means of Zn or Mg or with 2-thienylboronic acid (XV) and CO by means of a Pd(0) catalyst.
【1】 Sorbera, L.A.; Castaner, J.; Martin, L.; Indiplon. Drugs Fut 2003, 28, 8, 739. |
【2】 Wilcoxen, K.M.; Gross, R.S. (Neurocrine Biosciences Inc.); Synthesis of substd. pyrazolopyrimidines. WO 0110868 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 59947 | N-{3-[(E)-3-(dimethylamino)-2-propenoyl]phenyl}-N-methylacetamide | C14H18N2O2 | 详情 | 详情 | |
(XI) | 56012 | 1H-pyrazol-5-amine; 1H-pyrazol-5-ylamine | 916420-28-5 | C3H5N3 | 详情 | 详情 |
(XII) | 62961 | 4-bromo-1H-pyrazol-5-ylamine; 4-bromo-1H-pyrazol-5-amine | C3H4BrN3 | 详情 | 详情 | |
(XIII) | 62962 | N-[3-(3-bromopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-methylacetamide | C15H13BrN4O | 详情 | 详情 | |
(XIV) | 14103 | 2-Thiophenecarbonyl chloride | 5271-67-0 | C5H3ClOS | 详情 | 详情 |
(XV) | 62963 | 2-thiophenylboronic acid | C4H5BO2S | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(XI)Cyclization of 2-aminopyrazole (XI) with the acetamide (X) in AcOH gives the pyrazolo[1,5-a]pyrimidine derivative (XVI), which is finally acylated with 2-thienylcarbonyl chloride (XIV) by means of AlCl3.
【1】 Sorbera, L.A.; Castaner, J.; Martin, L.; Indiplon. Drugs Fut 2003, 28, 8, 739. |
【2】 Wilcoxen, K.M.; Gross, R.S. (Neurocrine Biosciences Inc.); Synthesis of substd. pyrazolopyrimidines. WO 0110868 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(X) | 59947 | N-{3-[(E)-3-(dimethylamino)-2-propenoyl]phenyl}-N-methylacetamide | C14H18N2O2 | 详情 | 详情 | |
(XI) | 56012 | 1H-pyrazol-5-amine; 1H-pyrazol-5-ylamine | 916420-28-5 | C3H5N3 | 详情 | 详情 |
(XIV) | 14103 | 2-Thiophenecarbonyl chloride | 5271-67-0 | C5H3ClOS | 详情 | 详情 |
(XVI) | 62964 | N-methyl-N-(3-pyrazolo[1,5-a]pyrimidin-7-ylphenyl)acetamide | C15H14N4O | 详情 | 详情 |